Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "EDS"

1516 News Found

Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants
Biotech | March 10, 2022

Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants

Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study


Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry
Biotech | March 09, 2022

Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry

Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder


SRL Diagnostics report indicates women neglect routine tests
Clinical Trials | March 09, 2022

SRL Diagnostics report indicates women neglect routine tests

Routine tests undertaken by women dropped by 35% in 2020


Industry upbeat on biopharma sector
News | March 08, 2022

Industry upbeat on biopharma sector

Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector


Organon declares paid time off for all employees on International Women’s Day
News | March 08, 2022

Organon declares paid time off for all employees on International Women’s Day

As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health


GOQii survey points to rise in women medical issues
Public Health | March 08, 2022

GOQii survey points to rise in women medical issues

Women's health is in fact a direct reflection of the nation's overall health


Thermo Fisher Scientific unveils new genetic analyzer
Medical Device | March 07, 2022

Thermo Fisher Scientific unveils new genetic analyzer

Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers


Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
Drug Approval | March 06, 2022

Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens

Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category